← Back to Screener
Quanterix Corporation Common Stock (QTRX)
Price$3.30
Value ScoreA
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-62.47%
Price vs S&P 500 (4W)16.82%
VGM Score59.58
Market Capitalization$155.45M
All Metrics
Book Value / Share (Quarterly)$6.00
P/TBV (Annual)1.81x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.60%
Cash Flow / Share (Quarterly)$-1.76
Price vs S&P 500 (YTD)-56.27%
Gross Margin (TTM)44.22%
Net Profit Margin (TTM)-71.86%
EPS (TTM)$-2.37
10-Day Avg Trading Volume1.17M
EPS Excl Extra (TTM)$-2.37
Revenue Growth (5Y)9.96%
EPS (Annual)$-2.51
ROI (Annual)-36.23%
Gross Margin (Annual)46.77%
Net Profit Margin (5Y Avg)-54.44%
Cash / Share (Quarterly)$2.11
Revenue Growth QoQ (YoY)20.05%
ROA (Last FY)-25.59%
Revenue Growth TTM (YoY)6.85%
EBITD / Share (TTM)$-2.71
ROE (5Y Avg)-19.20%
Operating Margin (TTM)-96.94%
Cash Flow / Share (Annual)$-1.71
P/B Ratio0.55x
P/B Ratio (Quarterly)0.59x
Net Income / Employee (Annual)$-238,100
EV / Revenue (TTM)0.82x
Net Interest Coverage (TTM)-143.25x
ROA (TTM)-25.96%
EPS Incl Extra (Annual)$-2.51
Current Ratio (Annual)2.84x
Quick Ratio (Quarterly)2.53x
3-Month Avg Trading Volume0.98M
52-Week Price Return-36.05%
Revenue / Employee (TTM)$322,200
Tangible BV / Share (Quarterly)$3.68
P/S Ratio (Annual)1.12x
Asset Turnover (Annual)0.33x
52-Week High$8.77
Operating Margin (5Y Avg)-63.13%
EPS Excl Extra (Annual)$-2.51
CapEx CAGR (5Y)-7.85%
Tangible BV CAGR (5Y)-3.15%
26-Week Price Return-54.55%
Quick Ratio (Annual)1.98x
13-Week Price Return-37.85%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.72x
Enterprise Value$119.27M
Revenue / Share Growth (5Y)2.22%
Asset Turnover (TTM)0.36x
Book Value / Share Growth (5Y)-0.48%
Revenue / Employee (Annual)$308,700
Inventory Turnover (Annual)1.69x
Pretax Margin (Annual)-80.83%
Cash / Share (Annual)$2.53
3-Month Return Std Dev85.62%
Gross Margin (5Y Avg)53.61%
Net Income / Employee (TTM)$-231,500
ROE (Last FY)-36.23%
Net Interest Coverage (Annual)-79.64x
EPS Basic Excl Extra (Annual)$-2.51
Receivables Turnover (TTM)5.27x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.37
Receivables Turnover (Annual)4.47x
ROI (TTM)-35.15%
P/S Ratio (TTM)1.07x
Pretax Margin (5Y Avg)-54.97%
Revenue / Share (Annual)$3.26
Tangible BV / Share (Annual)$3.51
Price vs S&P 500 (52W)-60.41%
Year-to-Date Return-48.11%
5-Day Price Return-5.71%
EPS Normalized (Annual)$-2.51
ROA (5Y Avg)-15.09%
Net Profit Margin (Annual)-77.14%
Month-to-Date Return7.84%
Cash Flow / Share (TTM)$-0.87
EBITD / Share (Annual)$-2.57
Operating Margin (Annual)-90.38%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-19.20%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-2.37
P/TBV (Quarterly)0.96x
P/B Ratio (Annual)1.00x
Inventory Turnover (TTM)1.97x
Pretax Margin (TTM)-73.39%
Book Value / Share (Annual)$6.33
Price vs S&P 500 (13W)-46.11%
Beta1.07x
Revenue / Share (TTM)$3.09
ROE (TTM)-35.17%
52-Week Low$2.40
vGradeA
gGradeC
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.37est. -0.55
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.44
2.44
2.44
2.44
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
QTRXQuanterix Corporation Common Stock | A | C | D | $3.30 |
| AAgilent Technologies Inc. | C | C | B | $135.44 |
| WATWaters Corp | D | C | C | $365.36 |
| ILMNIllumina Inc | D | D | B | $162.32 |
| MTDMettler-Toledo International | D | C | C | $1154.33 |
| RVTYRevvity, Inc. | C | D | C | $98.37 |
| BRKRBruker Corporation | D | D | B | $56.39 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $294.32 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $304.15 |
| AVTRAvantor, Inc. | B | D | C | $9.16 |
| TXG10x Genomics, Inc. Class A Common Stock | D | C | A | $31.04 |
About
Quanterix Corp develops ultra-sensitive digital immunoassay platforms that detect protein biomarkers at concentrations undetectable by conventional technologies. The company's Simoa platform enables precision diagnostics and life sciences research across multiple therapeutic areas, supported by a suite of instruments, assays, and laboratory services. With a global presence spanning North America, EMEA, and Asia Pacific, Quanterix serves the growing market for advanced biomarker detection in healthcare and research.